1019 related articles for article (PubMed ID: 17451383)
1. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
3. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
4. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
6. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
7. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
Koperski JA; Orenberg EK; Wilkinson DI
Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
9. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
10. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
Mapar MA; Omidian M
J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938
[TBL] [Abstract][Full Text] [Related]
11. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
12. [Effect of minoxidil on hair growth in androgenic alopecia in women].
Brzezińska-Wcisło L
Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of minoxidil in chemotherapy-induced alopecia.
Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
[TBL] [Abstract][Full Text] [Related]
14. Topical minoxidil therapy for hair regrowth.
Rumsfield JA; West DP; Fiedler-Weiss VC
Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
[TBL] [Abstract][Full Text] [Related]
15. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Olsen EA; Carson SC; Turney EA
Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
17. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N
Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234
[TBL] [Abstract][Full Text] [Related]
18. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
Hoedemaker C; van Egmond S; Sinclair R
Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
